Lack of CD44 variant 6 expression in rectal cancer invasive front associates with early recurrence

doi:10.3748/wjg.v18.i33.4549

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 33

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4019)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-3) series.

Item

Count

PDF

340

HTML

3161

Figures (1-2)

280

Tables (1-3)

238

Sum=4019

Sep 7, 2012 (publication date) through Jan 12, 2025

Times Cited of This Article

Times Cited (20)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Sep 7, 2012; 18(33): 4549-4556
Published online Sep 7, 2012. doi: 10.3748/wjg.v18.i33.4549

Full Size Figure Download Figure

Figure 1 The immunohistochemistry for CD44 variant 6 and Pan-cytokeratin. A: The same tumor with “front-positive” membranous staining of CD44 variant 6 (CD44v6); B: Expanding growth pattern as shown with Pan-cytokeratin (Ck-Pan) staining; C: The same tumor with “front-negative” membranous staining of CD44v6; D: Infiltrating growth pattern as shown with Ck-Pan staining. Invasive front is indicated with arrows.

Citation: Avoranta ST, Korkeila EA, Syrjänen KJ, Pyrhönen SO, Sundström JTT. Lack of CD44 variant 6 expression in rectal cancer invasive front associates with early recurrence. World J Gastroenterol 2012; 18(33): 4549-4556
URL: https://www.wjgnet.com/1007-9327/full/v18/i33/4549.htm
DOI: https://dx.doi.org/10.3748/wjg.v18.i33.4549